Spontaneous initiation, promotion and progression of colorectal cancer in the novel A/J Min/+ mouse

International Journal of Cancer

Volumn 138, Issue 8, 2016, Pages 1936-1946

  Sødring, Marianne ^a   Gunnes, Gjermund ^a   Paulsen, Jan Erik ^a  

^a NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

Author keywords

A J Min + mouse; carcinoma; colorectal cancer; intestinal tumorigenesis

Indexed keywords

A J MIN 1 MOUSE; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER MODEL; CANCER SUSCEPTIBILITY; COLON CARCINOGENESIS; COLON CARCINOMA; COLON INJURY; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SMALL INTESTINAL LESION; SMALL INTESTINE DISEASE; ANIMAL; C57BL MOUSE; CARCINOGENESIS; COLORECTAL TUMOR; DISEASE MODEL; GENETICS; PATHOLOGY;

ANIMALS; CARCINOGENESIS; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; MALE; MICE; MICE, INBRED C57BL;

EID: 84958999097     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29928     Document Type: Article

References (46)

1. Ferlay J, Soerjomataram I, Ervik M, et al., GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]. 2013. Available at: http://globocan.iarc.fr (accessed May 21, 2015).
2. Kinzler KW, Vogelstein B., Lessons from hereditary colorectal cancer. Cell 1996; 87: 159-70.
3. Fodde R., The APC gene in colorectal cancer. Eur J Cancer 2002; 38: 867-71.
4. Fodde R, Smits R., Disease model: familial adenomatous polyposis. Trends Mol Med 2001; 7: 369-73.
5. Fodde R, Smits R, Clevers H., APC, signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer 2001; 1: 55-67.
6. Fodde R, Tomlinson I., Nuclear β-catenin expression and Wnt signalling: in defence. J Pathol 2010; 221: 239-41.
7. Fearnhead NS, Britton MP, Bodmer WF, et al., The ABC of APC. Hum Mol Genet 2001; 10: 721-33
8. Ilyas M, Straub J, Tomlinson IPM, et al., Genetic pathways in colorectal and other cancers. Eur J Cancer 1999; 35: 335-51.
9. Kelloff GJ, Schilsky RL, Alberts DS, et al., Colorectal adenomas: a prototype for the use of surrogate end points in the development of cancer prevention drugs. Clin Cancer Res 2004; 10: 3908-18.
10. Moser AR, Pitot HC, Dove WF., A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 1990; 247: 322-4.
11. Paulsen JE., Modulation by dietary factors in murine FAP models. Toxicol Lett 2000; 112-113: 403-9.
12. Van Es JH, Giles RH, Clevers HC., The many faces of the tumor suppressor gene APC. Exp Cell Res 2001; 264: 126-34.
13. Su LK, Kinzler KW, Vogelstein B, et al., Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 1992; 256: 668-70.
14. Srivastava S, Verma M, Henson DE., Biomarkers for early detection of colon cancer. Clin Cancer Res 2001; 7: 1118-26.
15. Bird RP., Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett 1987; 37: 147-51.
16. Bird RP, Good CK., The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. Toxicol Lett 2000; 112-113: 395-402.
17. Paulsen JE, Namork E, Steffensen IL, et al., Identification and quantification of aberrant crypt foci in the colon of Min mice-a murine model of familial adenomatous polyposis. Scand J Gastroenterol 2000; 35: 534-9.
18. Paulsen JE, Løberg EM, Ølstørn HB, et al., Flat dysplastic aberrant crypt foci are related to tumorigenesis in the colon of azoxymethane-treated rat in the colon of azoxymethane-treated rat. Cancer Res 2005; 65: 121-9.
19. Paulsen JE, Steffensen IL, Løberg EM, et al., Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon. Cancer Res 2001; 61: 5010-15.
20. Mekada K, Abe K, Murakami A, et al., Genetic differences among C57BL/6 substrains. Exp Anim 2009; 58: 141-9.
21. Halberg RB, Waggoner J, Rasmussen K, et al., Long-lived Min mice develop advanced intestinal cancers through a genetically conservative pathway. Cancer Res 2009; 69: 5768-75.
22. Hinoi T, Akyol A, Theisen BK, et al., Mouse model of colonic adenoma-carcinoma progression based on somatic Apc inactivation. Cancer Res 2007; 67: 9721-30.
23. Rosenberg DW, Giardina C, Tanaka T., Mouse models for the study of colon carcinogenesis. Carcinogenesis 2009; 30: 183-96.
24. Glickman LT, Suissa S, Fleiszer DM., Proliferative characteristics of chronic crypt cells in C57BL/6J and A/J mice as predictors of subsequent tumor formation. Cancer Res 1987; 47: 4766-70.
25. Papanikolaou A., Sequential and morphological analyses of aberrant crypt foci formation in mice of differing susceptibility to azoxymethane-induced colon carcinogenesis. Carcinogenesis 2000; 21: 1567-72.
26. Ølstørn HB., The effect of acrylamide and glycidamide on intestinal carcinogenesis in mice. Ph.D thesis, University of Oslo: Norwegian Institute of Public Health, 2009. 63 pp. ISSN 1501-7710, nr. 825.
27. Flurkey K, Currer JM, Harrison DE., Mouse models in ageing research. In:, Fox JG, Barthold S, Davisson M, Newcomer CE, Quimby FW, Smith A, eds. The mouse in biomedical research: normative biology, husbandry, and models. Burlington, MA: Academic Press, 2006. 637-72.
28. Sødring M, Oostindjer M, Egelandsdal B, et al., Effects of hemin and nitrite on intestinal tumorigenesis in the A/J Min/+ mouse model. PLoS One 2015; 10: e0122880.
29. Moolenbeek C, Ruitenberg EJ., The "Swiss roll": a simple technique for histological studies of the rodent intestine. Lab Anim 1981; 15: 57-9.
30. Paulsen JE, Elvsaas IK, Steffensen IL, et al., A fish oil derived concentrate enriched in eicosapentaenoic and docosahexaenoic acid as ethyl ester suppresses the formation and growth of intestinal polyps in the Min mouse. Carcinogenesis 1997; 18: 1905-10.
31. Amos-Landgraf JM, Heijmans J, Wielenga MCB, et al., Sex disparity in colonic adenomagenesis involves promotion by male hormones, not protection by female hormones. Proc Natl Acad Sci USA 2014; 111: 16514-19.
32. Paulsen JE, Steffensen I-L, Namork E, et al., Age-dependent susceptibility to azoxymethane-induced and spontaneous tumorigenesis in the Min/+ mouse. Anticancer Res 2003; 23: 259-65.
33. Steffensen I-LL, Schut HAJ, Paulsen JE, et al., Intestinal tumorigenesis in multiple intestinal neoplasia mice induced by the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine: perinatal susceptibility, regional variation, and correlation with DNA adducts. Cancer Res 2001; 61: 8689-96.
34. Yamada Y, Hata K, Hirose Y, et al., Microadenomatous lesions involving loss of Apc heterozygosity in the colon of adult Apc(Min/+) mice. Cancer Res 2002; 62: 6367-70.
35. Oyama T, Yamada Y, Hata K, et al., Further upregulation of beta-catenin/Tcf transcription is involved in the development of macroscopic tumors in the colon of ApcMin/+ mice. Carcinogenesis 2008; 29: 666-72.
36. Chung HY, Cesari M, Anton S, et al., Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res Rev 2009; 8: 18-30.
37. Kwong LN, Dove WF., APC and its modifiers in colon cancer. Adv Exp Med Biol 2009; 656: 85-106.
38. Moser AR, Dove WRF, Roth KA, et al., The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system. J Cell Biol 1992; 116: 1517-26.
39. Svendsen C, Alexander J, Knutsen HK, et al., The min mouse on FVB background: susceptibility to spontaneous and carcinogen-induced intestinal tumourigenesis. Anticancer Res 2011; 31: 785-8.
40. Kwong LN, Shedlovsky A, Biehl BS, et al., Identification of Mom7, a novel modifier of Apc(Min/+) on mouse chromosome 18. Genetics 2007; 176: 1237-44.
41. Paulsen JE, Steffensen IL, Andreassen A, et al., Neonatal exposure to the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine via breast milk or directly induces intestinal tumors in multiple intestinal neoplasia mice. Carcinogenesis 1999; 20: 1277-82.
42. Cooper HS, Chang W-CL, Coudry R, et al., Generation of a unique strain of multiple intestinal neoplasia (Apc(+/Min-FCCC)) mice with significantly increased numbers of colorectal adenomas. Mol Carcinog 2005; 44: 31-41.
43. Cooper HS, Everley L, Chang WC, et al., The role of mutant Apc in the development of dysplasia and cancer in the mouse model of dextran sulfate sodium-induced colitis. Gastroenterology 2001; 121: 1407-16.
44. Amos-Landgraf JM, Kwong LN, Kendziorski CM, et al., A target-selected Apc-mutant rat kindred enhances the modeling of familial human colon cancer. Proc Natl Acad Sci USA 2007; 104: 4036-41.
45. Iwamoto M., Expression of beta-catenin and full-length APC protein in normal and neoplastic colonic tissues. Carcinogenesis 2000; 21: 1935-40.
46. Femia A, Pietro Luceri C, Soares PV, et al., Multiple mucin depleted foci, high proliferation and low apoptotic response in the onset of colon carcinogenesis of the PIRC rat, mutated in Apc. Int J Cancer 2015; 136: E488-E495.